Insider Transactions in Q3 2024 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
830
+4.12%
|
-
|
|
Sep 18
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Other acquisition or disposition
|
Indirect |
7,250
-100.0%
|
-
|
|
Sep 18
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
870
-3.68%
|
-
|
|
Sep 17
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
300
-1.25%
|
-
|
|
Sep 03
2024
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
744
+3.69%
|
$12,648
$17.13 P/Share
|
|
Sep 03
2024
|
Joseph Douglas Lyon |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-1.39%
|
$4,515
$35.3 P/Share
|
|
Sep 03
2024
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800
+3.15%
|
$13,600
$17.13 P/Share
|
|
Sep 03
2024
|
Atabak Mokari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-1.21%
|
$5,005
$35.3 P/Share
|
|
Sep 03
2024
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
916
+0.54%
|
$15,572
$17.13 P/Share
|
|
Sep 03
2024
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
232
-0.27%
|
$8,120
$35.3 P/Share
|
|
Sep 03
2024
|
William Guyer Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-4.02%
|
$8,505
$35.3 P/Share
|
|
Sep 03
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-62.35%
|
$350,000
$35.3 P/Share
|
|
Sep 03
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.4%
|
$210,000
$21.65 P/Share
|
|
Sep 03
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,006
+2.08%
|
$17,102
$17.13 P/Share
|
|
Sep 03
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-1.1%
|
$8,890
$35.3 P/Share
|
|
Aug 26
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,101
-11.79%
|
$108,535
$35.71 P/Share
|
|
Aug 01
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
150
-100.0%
|
$5,700
$38.5 P/Share
|
|
Aug 01
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
150
+50.0%
|
$750
$5.86 P/Share
|
|
Aug 01
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-62.35%
|
$380,000
$38.67 P/Share
|
|
Aug 01
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.4%
|
$210,000
$21.65 P/Share
|
|
Aug 01
2024
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,773
-22.68%
|
$1,286,601
$37.94 P/Share
|
|
Aug 01
2024
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+28.12%
|
$120,000
$2.81 P/Share
|
|
Jul 31
2024
|
Joseph K Belanoff Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
259,583
-32.5%
|
$9,864,154
$38.67 P/Share
|
|
Jul 31
2024
|
Joseph K Belanoff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
450,000
+36.03%
|
$1,350,000
$3.29 P/Share
|
|
Jul 01
2024
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-34.99%
|
$160,000
$32.49 P/Share
|
|
Jul 01
2024
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.92%
|
$55,000
$11.35 P/Share
|
|
Jul 01
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-62.35%
|
$320,000
$32.49 P/Share
|
|
Jul 01
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.4%
|
$210,000
$21.65 P/Share
|
|
Jul 01
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,000
-29.5%
|
$352,000
$32.49 P/Share
|
|
Jul 01
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+22.78%
|
$33,000
$3.29 P/Share
|
|
Jul 01
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$70,400
$32.81 P/Share
|
|
Jul 01
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|